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Abstract
Explants of tissue derived from the medial collateral ligament (MCL) of normal and pregnant NZW rabbits cultured in the
presence of substance P (SP), calcitonin gene-related peptide (CGRP), or both neuropeptides were found to have altered
mRNA levels for a number of relevant molecules. Using a very efficient RNA isolation method, semi-quantitative RT-PCR
and rabbit-specific primers, mRNA for growth factors (TGFL, bFGF, IGF-2, ET-1), cytokines (IL-1, TNF), enzymes (COX-
2, iNOS), metalloproteinases (collagenase, stromelysin) and metalloproteinase inhibitors (TIMP-1, TIMP-2) were assessed
after culture with or without neuropeptide. The results indicate that SP was effective in lowering mRNA levels for all of the
molecules assessed in RNA from normal ligaments except IL-1L, IGF-2 and TIMP-1, for which there was no significant
effect. Similarly, CGRP was effective in lowering mRNA levels for all molecules except TNF, ET-1 and the TIMPs. The
extent of the lowering of mRNA levels was both molecule-specific and neuropeptide-specific. When the experiments were
repeated with ligament tissue from pregnant animals, a very different pattern of responsiveness to the neuropeptides was
observed. While mRNA levels for 9/12 genes assessed were significantly affected by SP when normal MCL tissue was
investigated, pregnancy abolished all significant responsiveness to this neuropeptide except for iNOS mRNA levels. In the
case of iNOS mRNA, SP induced an increase in the steady-state levels, the opposite to what was observed with tissue from
non-pregnant animals. For CGRP and SP + CGRP, tissue from pregnant animals was still responsive, but the pattern of
responsiveness was changed from strictly a lowering of steady-state mRNA levels to elevations in mRNA levels for a number
of genes. These findings indicate that mRNA levels for a number of genes can be influenced by neuropeptides known to be in
ligaments. Thus, neuropeptides likely are important regulators of ligament cell metabolism. As the responsiveness to SP was
nearly completely abolished during pregnancy, neuroregulatory influences mediated by this peptide are altered in the
pregnant female. This loss of responsiveness to SP may also be one aspect of the analgesia associated with
pregnancy. ß 1998 Elsevier Science B.V. All rights reserved.
Keywords: Medial collateral ligament and neuropeptide; Molecular biology of ligament; Pregnancy and ligament biology;
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1. Introduction
Ligaments are dense bands of connective tissue
that function to stabilize joints (reviewed in [1^3]).
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Thus, the bone-ligament-bone complex serves to
guide, direct and restrict motion within physiologic
ranges. Ligaments, such as the medial collateral lig-
ament (MCL) of the knee, are composed of ¢bro-
blasts, a microvasculature, neural elements, mast
cells, and possibly other cell types (reviewed in [4]).
While the tissue is relatively hypovascular, it does
possess a signi¢cant blood supply which has been
partially characterized (reviewed in [5]). The neural
elements have been shown to contain the neuropep-
tides, substance P (SP) and calcitonin gene-related
peptide (CGRP) (reviewed in [5,6]). In the normal
ligament, the innervation appears to parallel the mi-
crovasculature and regulation of the microvascula-
ture by neuropeptides has been demonstrated 5,7,8].
Neuropeptides such as SP have also been shown to
in£uence connective tissue ¢broblast proliferation [9]
and Murphy and Hart [10] reported that SP could
also e¡ect the expression of mRNA for plasminogen
activator inhibitor-1 (PAI-1) by ligament-derived ¢-
broblasts. Therefore, in addition to a possible role in
proprioception [11], the innervation also likely con-
tributes to the endogenous regulation of ligaments
via neuropeptides.
A number of recent reports have focused on a
potential pro-in£ammatory role for neuropeptides,
such as SP, in the induction or progression of joint
in£ammation [6,12^14]. While denervation appears
to protect a joint from in£ammatory processes in
some circumstances [13], if the joint is functionally
compromised, such denervation can contribute to
loss of function and the development of conditions
such as osteoarthritis [15]. Thus, the innervation
likely serves a number of functions in normal joint
tissues, and neurogenic in£ammation may only be
one of these [10,16]. However, there is a paucity of
information available regarding a potential role for
the innervation in normal ligament function.
Recently, it has been shown that MCL function is
reversibly altered during pregnancy in the rabbit
[17,18]. During pregnancy the laxity, or looseness,
of the MCL increases, however, the high load behav-
ior of the tissue remains unaltered. In humans, a
similar pregnancy-associated alteration in joint laxity
has been documented [19], so the e¡ect observed in
the rabbit is not species-speci¢c. Furthermore, it has
recently been shown that pregnancy leads to altera-
tions in vasoregulation of the rabbit MCL and re-
sponsiveness to CGRP is abolished [25]. In the rabbit
MCL, SP has no apparent vasoregulatory activity
[7].
The present study was undertaken to address the
hypothesis that the neuropeptides SP and CGRP can
in£uence ligament cell activity via alterations in
mRNA levels for a number of relevant molecules
and this e¡ect is altered during pregnancy. While
the number of genes studied was not exhaustive,
they were chosen because of the potential of their
products to in£uence ligament function either di-
rectly or indirectly. Therefore, growth factors, cyto-
kines, enzymes whose products are potent mediators
(cyclooxygenase-2 [COX-2], inducible nitric oxide
synthase [iNOS]) or can degrade matrix molecules
(collagenase, stromelysin), and inhibitors of metallo-
proteinases which can block matrix degradation (tis-
sue inhibitors of metalloproteinases [TIMPs]) were
selected for study. Using a semi-quantitative RT-
PCR method, the results indicate that the neuropep-
tides can signi¢cantly alter steady state mRNA levels
for a number of the genes assessed, and the impact of
SP is nearly abolished during pregnancy, while that
of CGRP is modi¢ed.
2. Materials and methods
2.1. Animals
Female New Zealand White rabbits were obtained
from Rieman’s Furriers (St. Agatha, ON). Pregnant
rabbits were bred at 4.5 months of age and obtained
at 21 days of pregnancy. Age-matched non-pregnant
animals were also obtained at the same time. All
animals (six animals/group) were killed 8 days post
arrival (29 days pregnant) and the pregnancies
were con¢rmed at the time of death. Animals from
this source become skeletally mature at 9^10 months
of age and therefore the rabbits used in this study
are considered adolescents. Gestation in the rabbit
is 31^32 days so the animals used in this study
were 2^3 days pre-term. Animals were housed in ac-
cordance with Canadian Council on Animal Care
guidelines in the Faculty of Medicine vivarium until
death.
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2.2. Explant culture
Immediately after death, the MCL of each leg was
removed sterilely and divided into four equal pieces
of tissue (10^13 mg wet weight/piece). Variation in
the wet weight of tissue pieces from a single MCL
was less than 10%. Each piece of the MCL was
placed in 1 ml of serum-free tissue culture medium
(DMEM) (Gibco BRL; Burlington, ON) in a 24 well
tissue culture plate (Corning VWR; Missisauga,
ON). For each ligament, one explant served as a
control and the remaining explants received SP,
CGRP or SP+CGRP (Peninsula Laboratories; Bel-
mont, CA). The concentration of neuropeptide used
for this study (1037 M) was determined from pre-
vious studies where concentrations of 1039^1035 M
were studied and found to yield similar results
[10,21]. The explants were cultured for 24 h in a
humidi¢ed CO2 incubator at 37‡C as described pre-
viously [10,22].
2.3. Isolation of RNA
Total RNA was isolated from each explant using
the TRIspin method described previously [23] and
used in recent studies [21,24^27].
2.4. Polymerase chain reaction (PCR) primers
Primer sets for the molecules assessed in this study
were derived from the literature and GenBank se-
quences, and have been used in previous studies
[21,24^27]. Two independent isolates for each mole-
cule were cloned and sequenced to con¢rm the au-
thenticity of the PCR products. For those primers
derived from sequences of other species, the rabbit
PCR products were found to exhibit a high degree of
sequence homology to other species (Boykiw, Reno,
Sciore and Hart, submitted). Optimal conditions
(pH, bu¡er, temperature, number of cycles) for the
PCR reaction were determined for each primer set in
preliminary experiments using an Opti-Prime optimi-
zation kit (Stratagene, Los Angeles, CA).
2.5. Semi-quantitative RT-PCR
Reverse transcription (RT) was carried out with
1 Wg total RNA using the StrataScript RT-PCR kit
(Stratagene). Aliquots of cDNA were ampli¢ed by
PCR as described previously [23^27] using the appro-
priate primer sets. PCR products were separated in a
2% agarose gel at 60 V/cm in TAE bu¡er, the gels
stained with ethidium bromide, destained and then
photographed. The negatives were then analyzed us-
ing the Masterscan Interpretive Densitometer (CSPI,
Billerica, MA) and the RFLP Scanalytics software.
For all reported experiments, conditions were deter-
mined to be in the linear range for both the PCR
ampli¢cation and the image analysis system. Brie£y,
all of the samples were subjected to RT at the same
time and subsequently, all samples of cDNA ampli-
¢ed by PCR at the same time to avoid any potential
experiment to experiment variation in e⁄ciency.
Each RT sample was assessed for the housekeeping
gene, GAPDH cDNA, using 3 Wl of the 50 Wl of the
total volume of RT. Following 21^22 PCR cycles,
previously shown to yield results in the linear range
of the method, the volumes were normalized and the
PCR repeated to yield very similar GAPDH inte-
grated density values. Once the GAPDH values
were determined to be similar, and in the linear range
of detection, the same volumes of each sample in a
group were then used to assess the cDNA levels for
the remaining molecules of interest. Such an exper-
imental construct allowed for direct comparisons be-
tween the pregnant and non-pregnant samples. Inte-
grated density values for the genes in question were
normalized to the GAPDH values to yield a semi-
quantitative assessment. In the present study, values
for the control samples were set at 100% and the
values for the treated explants are expressed as per-
cent of control þ S.E.M.
2.6. Statistical analysis
Statistical analysis of results was performed using
the Excel 5.0 software and the ANOVA.
3. Results
3.1. In£uence of SP and CGRP on mRNA levels for
growth factors
One mechanism by which neuropeptides could in-
£uence ligament function is via an impact on the
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expression of growth factors known to regulate ma-
trix molecule expression in these connective tissues
[22,24,27] or known to be present in ligaments
[24,27]. Such growth factors could be the products
of resident mast cells, ¢broblasts or endothelial cells
in the tissue (discussed in [16]).
Expression of TGFL mRNA was found to be sig-
ni¢cantly depressed following exposure of normal
MCL tissue to 1037 M SP, 1037 M CGRP or both
SP+CGRP, compared to untreated normal tissue
(Table 1). In contrast, mRNA levels for TGFL
were not signi¢cantly altered when tissue from preg-
nant animals was exposed to either SP or CGRP.
However, exposure to SP+CGRG did lead to a sig-
ni¢cant depression of TGFL mRNA levels (Table 2).
Similar to the TGFL results, mRNA levels for bFGF
were signi¢cantly depressed following exposure of
normal MCL tissue to SP, CGRP or SP+CGRP (Ta-
ble 1). The pattern of responsiveness of the MCL
from pregnant animals for bFGF mRNA levels
also paralleled the TGFL results except that the ele-
vations in mRNA observed in the presence of CGRP
were signi¢cant (Table 2). Again, mRNA levels for
bFGF were depressed on exposure to SP+CGRP
(Table 2).
The pattern of responsiveness of normal MCL tis-
sue for IGF-2 mRNA di¡ered from that observed
for the previous two growth factors. Exposure to
SP alone did not signi¢cantly in£uence IGF-2
mRNA levels, however, levels were signi¢cantly de-
pressed in the presence of CGRP or SP+CGRP (Ta-
ble 1). Therefore, mRNA levels for this growth fac-
tor appear to be regulated by CGRP, but not SP, in
normal MCL tissue. Exposure of MCL tissue from
pregnant animals to the neuropeptides led to ¢ndings
somewhat opposite to those detected with normal
tissue. That is, exposure to SP again led to a non-
signi¢cant depression in IGF-2 mRNA levels, pri-
marily due to animal to animal variation, but expo-
sure to CGRP or CGRP+SP led to signi¢cant eleva-
tions in mRNA levels (Table 2). Thus pregnancy
appears to lead to conditions where CGRP respon-
siveness is not only reversed, but is actually enhanced
with respect to IGF-2 mRNA.
The growth factor ET-1 is primarily produced by
endothelial cells [28]. As many of the SP- and
CGRP-containing neural ¢bers are found in close
association with blood vessels in ligaments [6,14], it
was possible that some of the e¡ects of these neuro-
peptides could be at the level of the endothelial cells.
However, exposure of normal MCL tissue to SP,
CGRP or CGRP+SP did not lead to signi¢cant
changes in mRNA levels for this growth factor (Ta-
ble 1). In contrast, when tissue from pregnant ani-
mals was studied, the MCL tissue was still unrespon-
sive to SP, but exposure to CGRP or SP+CGRP led
to a signi¢cant elevation in mRNA levels for this
growth factor (Table 2).
Table 1
In£uence of SP and CGRP on mRNA levels in MCL tissue from normal rabbits
Gene SP CGRP SP+CGRP
% control Signi¢cance % control Signi¢cance % control Signi¢cance
TGF-L 73.6 þ 4.6 0.0006 75.9 þ 5.8 0.003 64.6 þ 17.3 0.014
bFGF 55.8 þ 17.1 0.002 37.5 þ 9.1 0.000001 39.1 þ 14.1 0.0001
IGF-2 83.1 þ 8.6 (NS) 29.5 þ 8.9 0.0005 52.9 þ 9.3 0.009
ET-1 60.1 þ 13.6 (NS) 114.7 þ 6.2 (NS) 136.3 þ 24.5 (NS)
IL-1L 47.7 þ 3.8 0.0008 74.1 þ 3.3 0.0008 79.8 þ 11.4 (NS)
TNF 58.4 þ 17.5 0.026 108.1 þ 9.7 (NS) 123.5 þ 14.4 (NS)
COX-2 31.3 þ 37.0 0.004 17.2 þ 12.9 0.0000002 15.4 þ 10.3 0.0000001
iNOS 44.5 þ 12.4 0.013 43.4 þ 8.5 0.01 59.6 þ 8.5 0.049
Collagenase 32.9 þ 36.9 0.0007 13.6 þ 22.0 0.0000003 11.1 þ 21.5 0.0000002
Stromelysin 52.4 þ 12.7 0.0008 50.5 þ 6.7 0.0001 47.4 þ 9.5 0.0001
TIMP-1 96.4 þ 3.6 (NS) 95.8 þ 9.5 (NS) 112.2 þ 8.5 (NS)
TIMP-2 71.2 þ 14.1 0.029 83.3 þ 9.2 (NS) 68.9 þ 10.3 0.005
The indicated values represent the mean þ S.E.M. of normalized values from non-pregnant animals. Values for untreated explants
(controls) were set at 100% and the values for explants cultured in the presence of SP, CGRP, or SP+CGRP are reported as percent
of the control values. P values were determined using ANOVA. (NS) = not signi¢cantly di¡erent from untreated values.
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3.2. E¡ect of neuropeptides on mRNA levels for
cytokines, COX-2 and iNOS
A number of studies have implicated neuropepti-
des such as SP and CGRP in either the induction or
perpetuation of in£ammatory processes in joints [12^
14]. Therefore, the e¡ect of exposure to neuropepti-
des on mRNA levels for the cytokines IL-1L and
TNF was investigated, as well as mRNA levels for
the enzymes COX-2 and iNOS. COX-2 is an induci-
ble enzyme responsible for synthesis of prostaglan-
dins (PG) such as PGE2, which are associated with
in£ammatory states (reviewed in [29]). iNOS is an
inducible form of nitric oxide synthase which gener-
ates NO, a potent mediator of a number of cellular
activities (reviewed in [30]).
Exposure of normal MCL tissue to SP, CGRP or
SP+CGRP lead to signi¢cant depression of mRNA
levels for IL-1L only following culture with SP or
CGRP, and SP was more e¡ective than CGRP (Ta-
ble 1). In contrast, exposure of MCL tissue from
pregnant animals to SP, CGRP or SP+CGRP had
no signi¢cant e¡ect on mRNA levels (Table 2). Thus,
pregnancy leads to the abolishment of a neuropep-
tide e¡ect on mRNA levels for this cytokine.
Interestingly, exposure of normal MCL tissue to
the neuropeptides led to a di¡erent pattern of re-
sponsiveness for TNF mRNA levels. For this cyto-
kine, SP induced a depression in mRNA levels, but
CGRP and SP+CGRP exerted no signi¢cant e¡ect
on mRNA levels for TNF (Table 1). When MCL
tissue from pregnant animals was investigated, a pat-
tern similar to what was observed previously for
IGF-2 was again observed for TNF mRNA levels
(Table 2). That is, the responsiveness to SP was ab-
rogated during pregnancy and exposure to CGRP
and CGRP+SP now led to a signi¢cant enhancement
of mRNA levels.
When normal MCL tissue was exposed to SP,
CGRP, or SP+CGRP, there was a consistent depres-
sion in mRNA levels for COX-2 (Table 1). In the
presence of the neuropeptides, the mean values for
mRNA levels were 31, 17 and 15% of control values,
respectively. In contrast, exposure of tissue from
pregnant animals led to a modest, but non-signi¢-
cant, enhancement of mRNA levels with SP, abroga-
tion of the response to CGRP, but a depression in
mRNA levels was still noted in the presence of
SP+CGRP (Table 2).
Exposure of normal MCL tissue to SP, CGRP or
SP+CGRP led to a depression in mRNA levels for
iNOS in all three cases (Table 1). However, exposure
of MCL tissue from pregnant animals to the neuro-
peptides led to a signi¢cant enhancement of mRNA
levels for iNOS in all cases (Table 2). Thus, during
pregnancy there was a somewhat opposite in£uence
of the neuropeptides on mRNA levels for this en-
zyme, compared to e¡ects on normal tissue.
Table 2
In£uence of SP and CGRP on mRNA levels in MCL tissue from pregnant rabbits
Gene SP CGRP SP+CGRP
% Control Signi¢cance % Control Signi¢cance % Control Signi¢cance
TGF-L 116.6 þ 7.5 (NS) 107.8 þ 11.2 (NS) 75.8 þ 8.6 0.023
bFGF 121.7 þ 8.5 (NS) 132.0 þ 8.1 0.03 72.9 þ 8.1 0.014
IGF-2 54.2 þ 25.5 (NS) 446.8 þ 18.2 0.002 517.7 þ 7.8 0.000006
ET-1 87.8 þ 13.3 (NS) 208.3 þ 15.1 0.008 158.1 þ 12.8 0.025
IL-1L 125.2 þ 11.3 (NS) 120.7 þ 16.7 (NS) 121.0 þ 18.9 (NS)
TNF 83.0 þ 14.5 (NS) 313.9 þ 23.4 0.016 338.4 þ 18.8 0.04
COX-2 132.7 þ 15.2 (NS) 87.5 þ 22.6 (NS) 40.7 þ 24.9 0.002
iNOS 156.4 þ 11.8 0.02 169.3 þ 14.0 0.021 176.5 þ 9.7 0.003
Collagenase 105.0 þ 19.0 (NS) 33.1 þ 32.8 0.0009 10.2 þ 8.0 0.000003
Stromelysin 130.9 þ 10.8 (NS) 93.0 þ 14.0 (NS) 61.2 þ 15.6 0.008
TIMP-1 111.9 þ 9.9 (NS) 85.1 þ 12.1 (NS) 83.2 þ 11.8 (NS)
TIMP-2 100.7 þ 6.2 (NS) 169.2 þ 9.0 0.002 87.5 þ 11.2 (NS)
The indicated values represent the mean þ S.E.M. of normalized values from 29-day pregnant animals. Values for untreated explants
(controls) were set at 100% and the values for explants cultured in the presence of SP, CGRP, or SP+CGRP are reported as percent
of the control values. P values were determined using ANOVA. (NS)=not signi¢cantly di¡erent from untreated values.
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3.3. Impact of neuropeptides on mRNA levels for
metalloproteinases and TIMPs
The matrix metalloproteinases collagenase (MMP-
1) and stromelysin (MMP-3) are important extracel-
lular enzymes which can a¡ect connective tissue turn-
over (reviewed in [31,32]). The activity of such pro-
teinases is balanced by the presence of TIMPs
(reviewed in [32]). One mechanism by which neuro-
peptides could in£uence ligament regulation is via an
impact on the expression of mRNA for these critical
matrix components.
Exposure of normal MCL tissue to SP, CGRP or
SP+CGRP led to a depression of mRNA levels for
both collagenase and stromelysin, in all cases (Table
1). For collagenase, CGRP and CGRP+SP were
more e¡ective than SP alone. However, in all cases
the depression in mRNA levels was signi¢cant. While
the e¡ect of the neuropeptides on stromelysin
mRNA levels was similar, the extent of the depres-
sion was less than that observed for collagenase (Ta-
ble 1). Thus, for SP, CGRP and CGRP+SP, the
values were 52, 50 and 47% of control values, respec-
tively.
When similar experiments were performed with
tissue from pregnant animals, a somewhat di¡erent
pattern of results were obtained (Table 2). Pregnancy
led to an abrogation of the in£uence of SP for both
enzymes. In the case of collagenase, responsiveness
to CGRP and CGRP+SP was maintained during
pregnancy and mRNA levels were again depressed.
However, for stromelysin mRNA CGRP had no ef-
fect in the pregnant state, but a signi¢cant depression
of mRNA levels was still observed in the presence of
SP+CGRP (Table 2).
In contrast to the metalloproteinases, the neuro-
peptides had no detectable in£uence on TIMP-1
mRNA levels when either MCL tissue from non-
pregnant or pregnant animals was examined (Tables
1 and 2). Interestingly, exposure to SP or SP+CGRP
lead to signi¢cantly lower levels of mRNA for
TIMP-2 when normal tissue was investigated (Table
1). Responsiveness to SP and SP+CGRP was found
to be abrogated in the pregnant state for TIMP-2,
but exposure to CGRP led to a signi¢cant increase in
mRNA levels for this TIMP (Table 2). This latter
¢nding was opposite to what was obtained with nor-
mal tissue.
4. Discussion
The results presented in this report demonstrate
that the neuropeptides SP and CGRP, normally
found in ligaments from a number of species [6,14],
can signi¢cantly in£uence steady-state mRNA levels
for a number of physiologically relevant molecules
(9/12 molecules tested for SP responsiveness and 8/
12 for CGRP). The second major ¢nding in this
study is that this responsiveness can be extensively
altered during pregnancy. These ¢ndings are sum-
marized in Table 3. As can be seen in Table 3,
most of the neuropeptide e¡ects on normal tissue
lead to a depression in mRNA levels, while the ef-
fects on MCL tissue from pregnant animals is more
variable and molecule-speci¢c. In fact, in the preg-
nant state the signi¢cant e¡ects were either primarily
abrogated, in the case of SP, or were now observed
to be primarily enhancements of mRNA levels, in the
case of CGRP (Table 3).
The observation in the present study that not all of
the mRNA species assessed were a¡ected by the neu-
ropeptides in the same manner, likely indicates that
there is either molecule-speci¢c responsiveness, or the
neuropeptides are exerting di¡ering e¡ects on di¡er-
ent cell populations under local and/or systemic in-
£uences. Thus, as ligaments are composed of ¢bro-
Table 3
Summary of signi¢cant changes in MCL mRNA levels induced
by neuropeptides
Gene Normal Pregnant
SP CGRP SP+CGRP SP CGRP SP+CGRP
IL-1L s s 3 3 3 3
TNF s 3 3 3 u u
COX-2 s s s 3 3 s
iNOS s s s u u u
TGFL s s s 3 3 s
bFGF s s s 3 u s
IGF-2 3 s s 3 u u
ET-1 3 3 3 3 u u
Collagenase s s s 3 s s
Stromelysin s s s 3 3 s
TIMP-1 3 3 3 3 3 3
TIMP-2 s 3 s 3 u 3
s= signi¢cant decrease; u= signi¢cant increase; 3= no signi¢-
cant change.
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blasts (and likely subsets of ¢broblasts), endothelial
cells in the microvasculature, mast cells and other
presently unde¢ned cell populations, it is not possible
to de¢ne the cell type responding to the neuropepti-
de(s). Perhaps future investigations using techniques
such as in situ hybridization, could shed new light on
this latter question. Previously, it was shown that
primary ¢broblasts from the MCL could respond
to SP, and therefore these cells at least, express func-
tional receptors for SP [10].
As the results summarized in Table 3 clearly indi-
cate, the in£uence of the neuropeptides on normal
tissues is a consistent lowering of the steady-state
mRNA levels, irrespective of the neuropeptide inves-
tigated. Steady-state mRNA levels for genes such as
IL-1L, COX-2, iNOS, TGFL, bFGF, collagenase and
stromelysin were consistently, and signi¢cantly, low-
er when normal ligament tissue was cultured with SP
or CGRP. In contrast, mRNA levels for ET-1 or
TIMP-1 were una¡ected by either neuropeptide,
alone or in combination. Such ¢ndings indicate
that there is speci¢city to the neuropeptide e¡ects
on mRNA levels in this tissue. Thus, in vivo expo-
sure to these neuropeptides, known to be in liga-
ments [5,6], could lead to modi¢cation of cellular
activities (IL-1L, TGFL, bFGF, COX-2, iNOS) or
extracellular turnover (collagenase, stromelysin).
Whether the changes observed for mRNA are corre-
lated with changes in protein levels or biological ac-
tivities remains to be con¢rmed (the samples of tissue
investigated in this study were too small to permit
accurate determinations of individual proteins or en-
zymatic activity). A previous study had indicated a
correlation between SP e¡ects on mRNA and PAI-1
activity [10]. However, even with this caveat the ¢nd-
ings do support the conclusion that endogenous neu-
ropeptides have the potential to regulate ligament
cell activity, predominately as a down-regulator of
metabolism, in normal tissue subjected to a normal
mechanical environment. The extent of the role for
such neuromodulation would depend on the number
of genes a¡ected, either directly or indirectly (via
e¡ects on pleiotrophic molecules such as growth fac-
tors). Thus, neuropeptides could also in£uence
mRNA levels for other proteinases, growth factors,
etc., which were not assessed in the present study.
The second major ¢nding of the present study is
that responsiveness to neuropeptides is altered by
pregnancy. Previously, it has been demonstrated
that the laxity of the rabbit MCL increases during
pregnancy ([17,18]; Hart, Frank and Shrive, in prep-
aration). Interestingly, the low load behavior of the
ligament was altered during pregnancy, but the high
load behavior (i.e. load to failure) was not altered.
As the water content of the tissue was not altered
during pregnancy, and the changes were reversed in
the post-partum period, this implied that reversible
changes in the matrix of the ligament occurred dur-
ing pregnancy. While the mechanism(s) responsible
for the observed mechanical changes in the tissue
are not known, the present results indicate that
such pregnancy-associated factors could be in£uenc-
ing some connective tissues, such as ligaments, indi-
rectly via alteration in responsiveness to endogenous
neuropeptides.
In the case of SP, where responsiveness was nearly
completely abolished during pregnancy, this could be
due to an alteration in the expression of SP receptors
on most cells during pregnancy or a modi¢cation of
post-receptor events. Both of these possibilities could
account for the loss of SP responsiveness during
pregnancy. In contrast, for CGRP it would appear
that receptors for this neuropeptide are still present
during pregnancy, but post-receptor events are some-
what altered. Such a possibility could account for the
change from CGRP exerting an inhibiting in£uence
to primarily an enhancing in£uence on mRNA levels
for most of the mRNA species assessed. Interest-
ingly, during pregnancy there is abolishment of
CGRP in£uences on vasoregulation in the MCL
[20], so the observed e¡ects of this neuropeptide on
mRNA levels in ligament explants likely involves
other cell types.
The ¢nding of a nearly complete loss of signi¢cant
responsiveness of the tissue to SP, a neuropeptide
also implicated in nociceptive ¢bers and pain percep-
tion [33], during pregnancy is very interesting from a
number of perspectives. First, loss of responsiveness
to SP may negate the regulatory e¡ect of this neuro-
peptide on endogenous cells and thus contribute in a
as yet unde¢ned manner to alterations in tissue func-
tion. Secondly, this loss of responsiveness to SP may
be indicative of a more generalized change in SP
responsiveness, including pain perception. In species
such as the rat [34] and the mouse [35,36], an anal-
gesia of pregnancy has been described. This phenom-
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enon is believed to involve endorphins and enkepha-
lins [33^36]. In the rat, this analgesia is most evident
towards the end of pregnancy [34], a time point sim-
ilar to that used in the present study. Therefore, the
loss of responsiveness to SP in the pregnant rabbit
MCL may be indicative of a generalized alteration in
sensitivity to this neuropeptide. Recently, we have
determined that responsiveness to SP is also nearly
completely abrogated in the Achilles tendon of pri-
migravida adolescent rabbits (Hart and Reno, un-
published), a ¢nding which supports this hypothesis.
In summary, the results presented in this study
demonstrate that SP and CGRP can in£uence
mRNA levels in the MCL for a number of genes,
but not others. Whether these changes are due to
e¡ects on transcription and/or RNA stability, and
whether the changes are accompanied by alterations
in protein levels, must await further studies with larg-
er samples of tissue. The ¢nding that responsiveness
of the MCL to neuropeptides can be in£uenced by
pregnancy indicates that the regulation of ligament
cells, and possibly ligament function, may have
unique features in females. Such gender-speci¢c in-
£uences could contribute to the incidence of ligament
injuries, the response to injury, and other knee path-
ologies, such as osteoarthritis, which occur more fre-
quently in females than males.
Acknowledgements
The authors thank Judy Crawford for excellent
secretarial assistance in the preparation of the manu-
script, and Drs. J.J. McDougall, R.C. Bray and C.B.
Frank for helpful discussions of the data and review
of the manuscript. This investigation was supported
by grants from the Medical Research Council of
Canada and The Arthritis Society (Canada).
D.A.H. is the Calgary Foundation-Grace Glaum
Professor in Arthritis Research.
References
[1] C.B. Frank, D.A. Hart, in: W. Leadbetter, J. Buckwalter, S.
Gordon (Eds.), Sports Induced In£ammation, AAOS, Park
Ridge, IL, 1990, pp. 555^564.
[2] C.B. Frank, D.A. Hart, in: V. Mow, A. Ratcli¡e, S. Woo
(Eds.), Biomechanics of Diarthrodial Joints, Springer-Ver-
lag, New York, NY, 1990, pp. 39^62.
[3] C.B. Frank, R.C. Bray, D.A. Hart, N.G. Shrive, B.J. Loitz,
J.R. Matyas, J.E. Wilson, in: F.H. Fu, C.D. Harner, K.G.
Vince (Eds.), Knee Surgery, William and Wilkins, Baltimore,
MD, 1994, pp. 189^227.
[4] P.G. Murphy, C.B. Frank, D.A. Hart, in: D. Jackson, S.
Arnoczky, S. Woo, C.B. Frank, T. Simon (Eds.), The Ante-
rior Cruciate Ligament, Raven Press, New York, NY, 1993,
pp. 165^177.
[5] R.C. Bray, M.R. Doschak, Curr. Opin. Orthop. 6 (1995) 41^
51.
[6] J.J. McDougall, R.C. Bray, K.A. Sharkey, Anat. Rec. 248
(1997) 29^39.
[7] W.R. Ferrell, J.J. McDougall, R.C. Bray, Br. J. Pharmacol.
121 (1997) 1397^1405.
[8] J.J. McDougall, W.R. Ferrell, R.C. Bray, J. Physiol. 503
(1997) 435^443.
[9] N.K. Harrison, K.E. Dawes, O.J. Kwon, P.J. Barnes, G.J.
Laurent, K.F. Chung, Am. J. Physiol. 268 (1995) 278^283.
[10] P.G. Murphy, D.A. Hart, Biochim. Biophys. Acta 1182
(1993) 165^174.
[11] M.S. Kocher, F.H. Fu, C.D. Harner, in: F.H. Fu, C.D.
Harner, K.G. Vince (Eds.), Knee Surgery, Williams and Wil-
kins, Baltimore, MD, 1994, pp. 231^249.
[12] F.Y. Lam, W.R. Ferrell, Neurosci. Lett. 105 (1989) 155^158.
[13] D. Veale, M. Farrell, O. Fitzgerald, Br. J. Rheumatol. 32
(1993) 413^416.
[14] K.W. Marshall, E. Theriault, D.A. Homonko, J. Rheumatol.
21 (1994) 883^889.
[15] B.L. O’Conner, D.M. Visco, K.D. Brandt, S.L. Myers, L.A.
Kalasinski, J. Bone Joint Surg. (A) 74 (1992) 367^376.
[16] D.A. Hart, C.B. Frank, R. Bray, in: S.L. Gordon, S.J. Blair,
L.J. Fine (Eds.), Repetitive Motion Disorders of the Upper
Extremity, AAOS, Park Ridge, IL, 1995, pp. 247^262.
[17] D.A. Hart, L. Roux, C.B. Frank, N.G. Shrive, in: Proceed-
ings of the 42nd Meeting of the Orthopaedic Research Soci-
ety, 1996, Abstract 792.
[18] C.B. Frank, D.A. Hart, N.G. Shrive, Osteoarth. Cart. (1998)
in press.
[19] C.W. Schauberger, B.L. Rooney, L. Goldsmith, D. Shenton,
P.D. Silva, A. Schaper, Am. J. Obstet. Gynecol. 174 (1996)
667^671.
[20] J.J. McDougall, R. Giles, R.C. Bray, D.A. Hart, Am. J.
Physiol. (1998) in press.
[21] D.A. Hart, J.M. Archambault, A. Kydd, C. Reno, C.B.
Frank, W. Herzog, Clin. Orthop. Relat. Res. (1998) in press.
[22] P.G. Murphy, B.J. Loitz, C.B. Frank, D.A. Hart, Biochem.
Cell Biol. 72 (1994) 403^409.
[23] C. Reno, L. Marchuk, P. Sciore, C.B. Frank, D.A. Hart,
BioTechniques 22 (1997) 1082^1086.
[24] P. Sciore, P.G. Murphy, D.A. Hart, Proceedings of the 42nd
Meeting of the Orthopaedic Research Society, 1996, Ab-
stract 49.
[25] L. Marchuk, P. Sciore, C. Reno, C.B. Frank, D.A. Hart,
Biochim. Biophys. Acta 1379 (1998) 171^177.
BBADIS 61755 8-10-98
D.A. Hart, C. Reno / Biochimica et Biophysica Acta 1408 (1998) 35^4342
[26] D.A. Hart, P. Sciore, R. Boykiw, C. Reno, Biochim. Bio-
phys. Acta (1998) in press.
[27] P. Sciore, R. Boykiw, D.A. Hart, J. Orthop. Res. (1998) in
press.
[28] D.J. Webb, Br. J. Clin. Pharmacol. 44 (1997) 9^20.
[29] C. Richardson, P. Emery, Drug Safety 15 (1996) 249^260.
[30] S.M. Sladek, R.R. Magness, K.P. Conrad, Am. J. Physiol.
272 (1997) R441^R463.
[31] D.A. Hart, Fibrinolysis 6, (Suppl. 1) (1992) 43^48.
[32] D.R. Edwards, P.P. Beaudry, T.D. Laing, Y. Kowal, K.J.
Leco, P.A. Leco, M.S. Lim, Int. J. Obes. 20 (1996) S9^
S15.
[33] H.-G. Schiable, B.D. Grubb, Pain 55 (1993) 5^54.
[34] A.R. Gintzler, Science 210 (1980) 193^195.
[35] A. Jayaram, P. Singh, H. Carp, Anesth. Analg. 80 (1995)
944^948.
[36] A. Jayaram, P. Singh, T. Noreuil, M.C. Fournie-Zaluski,
H.M. Carp, Anesth. Analg. 84 (1997) 355^358.
BBADIS 61755 8-10-98
D.A. Hart, C. Reno / Biochimica et Biophysica Acta 1408 (1998) 35^43 43
